Joseph Dichiara, DO
Pain Medicine · Knoxville, TNNPI 1104118835
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (36.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Nevro Corp. accounts for 85.6% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $38,722 and has fallen 74.0% since, to $10,085 in 2025. Among pain medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 385 payments — averaging $265.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$87K
- Abbott$10K
- Boston Scientific$4K
- Globus Medical$575
- Relievant Medsystems, Inc.$160
- Spinefrontier, Inc.$141
- plus $626 from 12 others
What the payments were for
- Consulting fees$21,85021%
- Speaking & faculty fees$36,73136%
- Travel & lodging$30,74830%
- Food & beverage$12,60012%
- Education$1960%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 254 | $87,399 |
| Abbott | 50 | $9,568 |
| Boston Scientific | 52 | $3,655 |
| Globus Medical | 2 | $575 |
| Relievant Medsystems, Inc. | 1 | $160 |
| Spinefrontier, Inc. | 3 | $141 |
| Medtronic(2 entities) | 5 | $135 |
| AbbVie(2 entities) | 3 | $84 |
| Collegium Pharmaceutical, Inc. | 3 | $77 |
| Pacira Pharmaceuticals Incorporated | 1 | $76 |
| SPR Therapeutics, Inc | 1 | $70 |
| Curonix LLC | 2 | $43 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Vertos Medical, Inc. | 2 | $31 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Fidia Pharma USA Inc. | 1 | $16 |
| Kaleo, Inc. | 1 | $16 |
| Sentynl Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Omnia$67,477
- Senza$8,674
- PROCLAIM$8,353
- Senza Spinal Cord Stimulation System$7,693
- SUPERION$1,383
- VERTIFLEX SUPERION$681
- WaveWriter Alpha Prime 16$375
- Intracept$320
- ETERNA$261
- GENERAL PAIN MANAGEMENT$120
- Penta SCS Leads$111
- InSpan$102
How this compares
$102,125 in reported general payments places this provider in the 95th percentile of 112 pain medicine providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxymorphone Hcl ErOxymorphone Hcl | 51 | $25,382 |
| Xtampza ErOxycodone Myristate | 20 | $8,400 |
| Oxycodone Hcl | 263 | $6,386 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 168 | $5,502 |
| Gabapentin | 219 | $3,101 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 108 | $3,091 |
| Naloxone Hcl | 28 | $1,902 |
| Morphine Sulfate ErMorphine Sulfate | 62 | $1,708 |
| Lidocaine | 20 | $1,613 |
| Tizanidine Hcl | 106 | $1,419 |
| Pregabalin | 41 | $617 |
| Diclofenac Sodium | 21 | $567 |
| Morphine Sulfate | 11 | $369 |
| Baclofen | 25 | $237 |
| Methocarbamol | 17 | $193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $77 | $8,40020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 112 pain medicine providers in Tennessee.
Other pain medicine in Knoxville
- Stephanie VanterpoolKnoxville$69K
- Kyle SnyderKnoxville$8K
- James ChooKnoxville$5K
- George MearsKnoxville$4K
- Matthew VanceKnoxville$3K
- Shravani DurbhakulaNashville$353K
- Herbert MeltzerNashville$43K
- Marc HuntoonNashville$37K
- Gregory BallChattanooga$35K
- Phillip GreenMemphis$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.